reviewNature Reviews Drug DiscoveryJun 19, 2003Closed access

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

JAJonathan A. Tobert

Merck & Co., Inc., Rahway, NJ, USA (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

871
total citations
FWCI
19.07
Percentile
100%
References
110
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Lovastatin
  • HMG-CoA reductase
  • Reductase
  • Cholesterol
  • Coronary heart disease
  • Pharmacology
  • Medicine
  • Enzyme
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.